Breast cancer Cancer Breast cancer
Conditions
Interventions
PMRT 1 hour prior to chemotherapy administration and daily thereafter for another 5 days (total of 6 PMRT sessions). Each session lasts for 25 minutes followed by 5 minutes of imagery techniques.
Sponsors
Hong Kong Health Services Research Fund (China)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with breast cancer and have no exposure to cytotoxic chemotherapeutic agent prior to the study (chemotherapy-naive) 2. Females between the age of 18 - 70 years 3. Clinical indication to receive adriamycin with cyclophosphamide (AC) as adjuvant or salvage chemotherapy for treatment of breast cancer 4. Able to read and write Chinese 5. Agree to sign the informed consent
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
Hong Kong
Outcome results
None listed